Vasopressin receptors modulate the pharmacological phenotypes of Cushing's syndrome.

doi:10.3109/07435809809032691

Back to search

Article

Vasopressin receptors modulate the pharmacological phenotypes of Cushing's syndrome.

Endocrine research - 1 Jan 2000

Arnaldi G, de Keyzer Y, Gasc J M, Clauser E, Bertagna X

Abstract excerpt

We have examined the expression profiles of the different vasopressin receptors (V1, V2, V3) that can be expressed in the three different types of tumors associated with Cushing's syndrome. V3 (V1b) receptor cDNA was cloned from a pituitary tumor responsible for Cushing's disease. We show that it...

Topics

Adrenal Cortex Neoplasms
Adrenal Glands
Bronchial Neoplasms
Carcinoid Tumor
Cushing Syndrome
Humans
Hydrocortisone
Isomerism
Phenotype
Pro-Opiomelanocortin
RNA, Messenger
Receptors, Vasopressin
Vasopressins

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.